These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 17332312)

  • 1. Notch signaling, gamma-secretase inhibitors, and cancer therapy.
    Shih IeM; Wang TL
    Cancer Res; 2007 Mar; 67(5):1879-82. PubMed ID: 17332312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational targeting of Notch signaling in cancer.
    Rizzo P; Osipo C; Foreman K; Golde T; Osborne B; Miele L
    Oncogene; 2008 Sep; 27(38):5124-31. PubMed ID: 18758481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging roles of the γ-secretase-notch axis in inflammation.
    Cheng YL; Choi Y; Sobey CG; Arumugam TV; Jo DG
    Pharmacol Ther; 2015 Mar; 147():80-90. PubMed ID: 25448038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notch signaling: an emerging therapeutic target for cancer treatment.
    Yuan X; Wu H; Xu H; Xiong H; Chu Q; Yu S; Wu GS; Wu K
    Cancer Lett; 2015 Dec; 369(1):20-7. PubMed ID: 26341688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma-secretase and the intramembrane proteolysis of Notch.
    Jorissen E; De Strooper B
    Curr Top Dev Biol; 2010; 92():201-30. PubMed ID: 20816396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of gamma-secretase modulation differentiates inhibitor compound selectivity between two substrates Notch and amyloid precursor protein.
    Yang T; Arslanova D; Gu Y; Augelli-Szafran C; Xia W
    Mol Brain; 2008 Nov; 1():15. PubMed ID: 18983676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
    Hales EC; Taub JW; Matherly LH
    Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small molecules that inhibit Notch signaling.
    De Kloe GE; De Strooper B
    Methods Mol Biol; 2014; 1187():311-22. PubMed ID: 25053499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Notch signaling pathway in esophageal adenocarcinoma.
    Wang Z; Chen J; Capobianco AJ
    Cell Mol Biol (Noisy-le-grand); 2015 Oct; 61(6):24-32. PubMed ID: 26518893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms and clinical prospects of Notch inhibitors in the therapy of hematological malignancies.
    Nefedova Y; Gabrilovich D
    Drug Resist Updat; 2008 Dec; 11(6):210-8. PubMed ID: 18951834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PEST domain mutations in Notch receptors comprise an oncogenic driver segment in triple-negative breast cancer sensitive to a γ-secretase inhibitor.
    Wang K; Zhang Q; Li D; Ching K; Zhang C; Zheng X; Ozeck M; Shi S; Li X; Wang H; Rejto P; Christensen J; Olson P
    Clin Cancer Res; 2015 Mar; 21(6):1487-96. PubMed ID: 25564152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.
    Kumar R; Juillerat-Jeanneret L; Golshayan D
    J Med Chem; 2016 Sep; 59(17):7719-37. PubMed ID: 27045975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notch signaling in breast cancer and tumor angiogenesis: cross-talk and therapeutic potentials.
    Shi W; Harris AL
    J Mammary Gland Biol Neoplasia; 2006 Jan; 11(1):41-52. PubMed ID: 16947085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that gamma-secretase-mediated Notch signaling induces neuronal cell death via the nuclear factor-kappaB-Bcl-2-interacting mediator of cell death pathway in ischemic stroke.
    Arumugam TV; Cheng YL; Choi Y; Choi YH; Yang S; Yun YK; Park JS; Yang DK; Thundyil J; Gelderblom M; Karamyan VT; Tang SC; Chan SL; Magnus T; Sobey CG; Jo DG
    Mol Pharmacol; 2011 Jul; 80(1):23-31. PubMed ID: 21450930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rethinking Gamma-secretase Inhibitors for Treatment of Non-small-Cell Lung Cancer: Is Notch the Target?
    Pine SR
    Clin Cancer Res; 2018 Dec; 24(24):6136-6141. PubMed ID: 30104200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of gamma-secretase affects proliferation of leukemia and hepatoma cell lines through Notch signaling.
    Suwanjunee S; Wongchana W; Palaga T
    Anticancer Drugs; 2008 Jun; 19(5):477-86. PubMed ID: 18418214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphenol A disrupts Notch signaling by inhibiting gamma-secretase activity and causes eye dysplasia of Xenopus laevis.
    Baba K; Okada K; Kinoshita T; Imaoka S
    Toxicol Sci; 2009 Apr; 108(2):344-55. PubMed ID: 19218331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient gamma-secretase inhibition accelerates and enhances fracture repair likely via Notch signaling modulation.
    Wang C; Shen J; Yukata K; Inzana JA; O'Keefe RJ; Awad HA; Hilton MJ
    Bone; 2015 Apr; 73():77-89. PubMed ID: 25527421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early regionalization of the otic placode and its regulation by the Notch signaling pathway.
    Abelló G; Khatri S; Giráldez F; Alsina B
    Mech Dev; 2007 Aug; 124(7-8):631-45. PubMed ID: 17532192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease.
    Martone RL; Zhou H; Atchison K; Comery T; Xu JZ; Huang X; Gong X; Jin M; Kreft A; Harrison B; Mayer SC; Aschmies S; Gonzales C; Zaleska MM; Riddell DR; Wagner E; Lu P; Sun SC; Sonnenberg-Reines J; Oganesian A; Adkins K; Leach MW; Clarke DW; Huryn D; Abou-Gharbia M; Magolda R; Bard J; Frick G; Raje S; Forlow SB; Balliet C; Burczynski ME; Reinhart PH; Wan HI; Pangalos MN; Jacobsen JS
    J Pharmacol Exp Ther; 2009 Nov; 331(2):598-608. PubMed ID: 19671883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.